Copyright
©The Author(s) 2024.
World J Clin Cases. May 26, 2024; 12(15): 2578-2585
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2578
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2578
Variable | Intervention group (n = 80) | Control group (n = 80) | P value |
Age (yr) | 58.6 ± 9.4 | 59.2 ± 10.2 | 0.64 |
Gender | 0.87 | ||
Male | 37 (52.9) | 36 (51.4) | |
Female | 33 (47.1) | 34 (48.6) | |
Education level | 0.76 | ||
Primary school or below | 15 (21.4) | 16 (22.9) | |
Middle school | 31 (44.3) | 30 (42.9) | |
High school or above | 24 (34.3) | 24 (34.3) | |
Marital status | 0.81 | ||
Married or cohabiting | 64 (91.4) | 63 (90.0) | |
Single, divorced, or widowed | 6 (8.6) | 7 (10.0) | |
Occupation | 0.69 | ||
Employed or self-employed | 39 (55.7) | 37 (52.9) | |
Retired or unemployed | 31 (44.3) | 33 (47.1) | |
Smoking status | 0.92 | ||
Current smoker | 11 (15.7) | 10 (14.3) | |
Former smoker or never smoker | 59 (84.3) | 60 (85.7) | |
Drinking status | 0.77 | ||
Current drinker | 13 (18.6) | 14 (20.0) | |
Former drinker or never drinker | 57 (81.4) | 56 (80.0) | |
Body mass index (kg/m2) | 25.4 ± 3.2 | 25.7 ± 3.6 | 0.54 |
Duration of hypertension (yr) | 8.3 ± 6.4 | 8.7 ± 7.2 | 0.71 |
Number of antihypertensive drugs | 0.83 | ||
One | 31 (44.3) | 29 (41.4) | |
Two or more | 39 (55.7) | 41 (58.6) | |
Systolic blood pressure (mmHg) | 149 ± 14 | 150 ± 15 | 0.67 |
Diastolic blood pressure (mmHg) | 91 ± 9 | 92 ± 10 | 0.59 |
Medication adherence score | |||
MMAS-8 | 6.2 ± 1.8 | 6.3 ± 1.9 | 0.68 |
Self-efficacy score | |||
SEMCDS | 68.4 ± 1.7 | 68.6 ± 1.8 | 0.51 |
Perceived benefits score | |||
HHBS | 16.8 ± 2.4 | 16.9 ± 2.6 | 0.32 |
Perceived barriers score | |||
HHBS | 11.2 ± 3.1 | 11.4 ± 3.3 | 0.49 |
Perceived susceptibility score | |||
HHBS | 14.6 ± 2.9 | 14.7 ± 3.1 | 0.56 |
Perceived severity score | |||
HHBS | 15.4 ± 2.7 | 1 .5 ± 2.8 | 0.68 |
Variable | Intervention group (n = 70) | Control group (n = 80) | Group-by-time interaction | ||||
Baseline | 3 months | 6 months | Baseline | 3 months | 6 months | P value | |
Systolic blood pressure (mmHg) | 149 ± 14 | 136 ± 12a | 133 ± 11a | 150 ± 14 | 145 ± 13 | 143 ± 12 | < 0.001 |
Diastolic blood pressure (mmHg) | 91 ± 9 | 83 ± 8a | 81 ± 7a | 92 ± 9 | 89 ± 8 | 88 ± 7 | < 0.001 |
Medication adherence score (MMAS-8) | 6.2 ± 1.8 | 7.4 ± 1.1a | 7.6 ± 1.0a | 6.1 ± 1.8 | 6.5 ± 1.7 | 6.7 ± 1.6 | < 0.001 |
Self-efficacy score (SEMCDS) | 68.4 ± 1.7 | 72.4 ± 1.5a | 73.2 ± 1.4a | 68.0 ± 1.7 | 69.5 ± 1.6 | 70.0 ± 1.5 | < 0.001 |
Perceived benefits score (HHBS) | 16.8 ± 2.4 | 18.2 ± 2.2a | 18.5 ± 2.1a | 16.7 ± 2.4 | 17.0 ± 2.3 | 17.2 ± 2.2 | < 0.001 |
Perceived barriers score (HHBS) | 11.2 ± 3.1 | 9.8 ± 2.9a | 9.5 ± 2.8a | 11.3 ± 3.1 | 10.9 ± 3.0 | 10.7 ± 2.9 | < 0.001 |
Perceived susceptibility score (HHBS) | 14.6 ± 2.9 | 16.0 ± 2.7a | 16.3 ± 2.6a | 14.5 ± 2.9 | 15.0 ± 2.8 | 15.2 ± 2.7 | < 0.001 |
Perceived severity score (HHBS) | 15.4 ± 2.7 | 16.8 ± 2.5a | 17.1 ± 2.4a | 15.3 ± 2.7 | 15.8 ± 2.6 | 16.0 ± 2.5 | < 0.001 |
- Citation: Wang HM, Chen Y, Shen YH, Wang XM. Evaluation of the effects of health education interventions for hypertensive patients based on the health belief model. World J Clin Cases 2024; 12(15): 2578-2585
- URL: https://www.wjgnet.com/2307-8960/full/v12/i15/2578.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i15.2578